68Ga-PSMA-11 is eliminated via the renal pathway, so that detection of disease with PET/CT using 68Ga-PSMA-11 may be limited by topographic proximity of tumor sites with the urinary tract or by superimposition of tumor sites and ureteric tracer accumulation [7]. Here, FOLH1 is linked to neoplasm.